Eprontia is a brand name for oral levetiracetam, an anti-epileptic drug (AED) used to treat partial-onset seizures in adults and children [1][2]. It is a liquid formulation designed for patients who have difficulty swallowing pills [3]. Eprontia is manufactured by UCB Pharma [4].
How does Eprontia work?
Eprontia, like other formulations of levetiracetam, works by affecting the release of certain neurotransmitters in the brain, though its exact mechanism of action is not fully understood [1]. It is thought to bind to the synaptic vesicle protein 2A (SV2A), which plays a role in regulating neurotransmitter release [1].
What conditions does Eprontia treat?
Eprontia is indicated for the treatment of partial-onset seizures in patients one month of age and older [2]. It can be used as monotherapy or as an adjunctive therapy in combination with other anti-epileptic drugs [2].
What is the difference between Eprontia and Keppra?
Keppra is another brand name for levetiracetam, also manufactured by UCB Pharma. Eprontia is a newer, liquid formulation of levetiracetam, whereas Keppra is available in both oral tablet and oral solution forms [3][5]. The primary distinction is Eprontia's specific development as an oral liquid for ease of administration [3].
Are there generic versions of Eprontia available?
Levetiracetam itself has generic versions available. However, Eprontia is a specific branded product, and its availability as a generic depends on patent protection and market exclusivity [4]. Information on the patent expiry for Eprontia would determine when generic competition could emerge.
What are the potential side effects of Eprontia?
Common side effects associated with levetiracetam formulations, including Eprontia, can include drowsiness, dizziness, fatigue, and behavioral changes such as aggression and mood disturbances [1]. Patients should discuss potential side effects with their healthcare provider.
How is Eprontia administered?
Eprontia is taken orally. The dosage is determined by a healthcare professional based on the patient's age, weight, and medical condition [2]. It can be taken with or without food [2].
Who is UCB Pharma, the maker of Eprontia?
UCB Pharma is a global biopharmaceutical company focused on neurology and immunology. They are known for developing and marketing treatments for conditions like epilepsy, Parkinson's disease, and rheumatoid arthritis [4].
Sources:
[1] https://www.webmd.com/drugs/2/drug-165420/levetiracetam-oral/details
[2] https://www.eprontia.com/
[3] https://www.usnews.com/medicides/pharmaceuticals/eprontia-levetiracetam-oral-solution-600141100220
[4] https://www.ucb.com/
[5] https://www.keppra.com/